Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin dosage and its effects on coronary aneurysm in Kawasaki disease
TCTR20260328007Phase 3Recruiting
- Sponsor
- N/A
- Start
- Apr 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in Kawasaki disease (KD), sponsored by N/A. Started Apr 2026; status: recruiting.
02
Drugs
aspirin
03
Conditions
Kawasaki disease (KD)
Beyond the preview
Go deeper on TCTR20260328007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260328007.